Upload
adriana-adriana
View
218
Download
0
Embed Size (px)
Citation preview
8/10/2019 C3_SA_Ancuta.pdf
1/44
SPONDILARTRITE(SpA)
CODRINA ANCUTAMD, PhD, seflucrari
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
2/44
SPONDILARTRITE
Grup de boli ce au incomun caracteristici
etiopatogenice, genetice,clinice & radiologice
sacroiliita & inflamatiever e ra a os care artrite periferice, entezite& dactilite manifestari extra-articulare (ocular, digestiv,
genito-urinar, cutanat ) asocierea HLA-B27+ barbat tanar (26 ani)
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
3/44
DURERELOMBARA INFLAMATORIE(CRITERII ASAS 2009)
Durere lombara cronica (> 3 luni)1. Varsta de instalare < 40 ani2. Debut insidios
. me orare cu e or u exerc ufizic
4. Lipsa ameliorarii in repaus5. Durerea nocturna
Necesare 4 din 5 criteriiCriteriile noi propuse raport optim
specificitate/sensibilitate >80%
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
4/44
CRITERIICLASIFICARESpA AXIALE (ASAS)
Sacroiliita imagisticplus
1.Durere lombara joasatip inflamator2.Artrita3.Uveita4.Dactilita
Durere lombara > 3 luniVarsta debut < 45 ani
HLA-B27+plus
2 din
.6.Entezita7.Boala intestinalainflamatorie8.Raspuns bun la AINS
9.Istoric familial10.HLA-B27+11.CRP crescut
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
5/44
SPONDILITA ANCHILOZANTA
SA
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
6/44
Definitie & date epidemiologice
Mecanisme imuno-patogenetice
Tablou clinic (articular & sistemic)
Investigatii paraclinice (biologice &imagistice)
Management
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
7/44
boala reumatismala inflamatorie cronica,imuna, de etiologie incomplet elucidata
teren susceptibilitate genetica (HLAB27+)
Definitie
scheletul axial & articulatiile sacroiliace(bilateral, simetric, marker SA)
-inferioare) & enteze & dactilita &manifestari extra-articulare (oculare,digestive, uro-genitale, cutanate)
evolutie spre anchiloza prin nlocuireainflamaiei cu os
Manifes-tari
Prevalenta = 0.5-1.5%
F:M = 1:4
Varsta debut = 16-35 ani (tipic)
Epidemio-logie
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
8/44
Definitie & date epidemiologice
Mecanisme imuno-patogenice
Tablou clinic (articular & sistemic)
Investigatii paraclinice (biologice &imagistice)
Management
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
9/44
Teoriipatogenice
MECANISME IMUNO-PATOGENICE
Factoriinfectiosi
(Klebsiella,Coli, gram-
HLA clasa I (B27-90%;B2701-09)agregabilitate familiala (15-20%)
1. Mimetismmolecular epitopi similariHLAB27 &bacterii gram-toleranta
imunologica;CD8+
2. Interactiunemoleculara
uscept -tate
genetica
intestinali)
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
10/44
Definitie & date epidemiologice
Mecanisme imuno-patogenetice
Tablou clinic (articular& sistemic)
Investigatii paraclinice (biologice &imagistice)
Management
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
11/44
MODALITATI DE DEBUT
TIPIC, AXIAL
lo m b o -sa c ra t : lo wb a c k p a in in
at! de ulei la
ATIPIC
p e rife ric a rtic u la r (oligo-, mono- sau
oliartrite erifericenivel cervical
C e rv i c a l lombar
dureri vertebraleinflamatorii
redoare matinalavertebrala
asimetrice,articulatiile mari MI
entezitic (talalgii,toracodinii)
siste m ic (leziuniinflamatorii ocular,etc)
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
12/44
ARTICULATII AFECTATE
AXIAL lombar, dorsal &cervicalartic interapof post &
- -
PERIFERIC Artic mari mbinferioare, asimetric=oligo-artrite
sternale ligamente interspinos,prevertebral,paravertebral
articulatii sacro-iliace(bilateral & simetric!)artic coxo-femurala coxita!
Orice altaarticulatie
Entezitetendinitaachiliana &fasciita plantara
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
13/44
CLINIC PERIOADA DESTARE
durere lombara joasa (lo w b a c k p a in ),inflamatorie & sciatica in bascul! redoare (st iffn e ss) matinala vertebrala >30 minute rahialgii dorsale & cervicale in p a ta ule i
oli o-artrite eriferice asimetrice artic mari mbinf!)toracodinii difuzeTalalgii (tendinita achiliana / aponevrozitaplantar!) sau alte entezite (tuberozitate ant tibie)
afectare oculara pol ant (conjunctivite, irite,
irido-ciclite; bilat & recidivante) sau alte manifextra-articulare
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
14/44PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
15/44
CLINIC PERIOADA TARDIVA algii axiale & periferice = absente (osificare!)
+rahialgii segm dorsal superior & cervical,entezite & artrite perif disfunctie respiratorie tip restrictiv
OBIECTIV
anterioara cap & accentuare cifoza dorsala &rectitudine lombar & abdomen proeminent &flexum sold & genunchi rigiditatea axiala
amplian$a pulmonara redusa mers dificil & limitare perimetru mers fenomene viscerale: insuficien$a aortica, secheleuveita, iridoc iclita, neurologic
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
16/44
MANIFESTARI EXTRA-ARTICULARE
Frecv mare, afectare pol anterior, recurente,bilateral
conjunctivita
Irita, irido-ciclita
Oculare
insuficienta aortica aortita SA & tulburari conducere-vasculare
inflamatie artic costo-vertebrale & costo-sternale osificare amplitudine miscarirespiratorii & disfunctie ventiltorie restrictiva
fibroza pulmonara - fara expresie clinica
Pulmonare
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
17/44
MANIFESTARI EXTRA-ARTICULARE
nefropatia cu IgA sau amiloidozasecundara inflama$iei cronice
Renale
fract vertebrale (coloana osificat!,- rigid!din SA se fractureaza ca un o
lung)ce
inflama$ie macro- &
microscopicaIntestinale
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
18/44
Definitie & date epidemiologice
Mecanisme imuno-patogenetice
Tablou clinic (articula & sistemic) Investigatii paraclinice (biologice &
imagistice)
Management
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
19/44
EXPLORARE
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
20/44
Rg bazinpt SI (tub la 45 grade)
Sacroiliita bilaterala & simetricaCLASIFICAREA CALIN
Stadiul O= margine artic continuA, spatiu articnormal
Stadiul I aspect noros, flu, incert al articula$iei;
Stadiul II= eroziuni rebord articular & pseudo-largire & scleroza versanti artic
Stadiul III=pensare spatiu & scleroza reborduri Stadiul IV = fuziune osoasa & anchiloza
articulatia fantoma
Rg bazinpt sacroiliace (tub 45 grade)
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
21/44
Rg coloana fata & profil
alinierea corpi vertebralivertebra patrata Romanus SINDESMOFITE = semn patognomonic SA,
rezultat al osific!rii fibrelor externe ale inelului
coloana de BAMBUS =tardiv; sindesmofite &linia de tramvai (osificare AIP) & firul electric(osificare ligamente inter-spinoase);
spondilodiscitaosteoporoza
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
22/44
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
23/44
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
24/44
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
25/44
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
26/44
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
27/44
DIAGNOSTIC DIFERENTIAL
alte spondilartrite alte artrite sacro-iliace (infec $ioase piogene,TB, sarcoidoza, ...)
hernia disc (durerea lombara mecanica v
durerea inflamatorie!!!) maladia Scheurmann (cifoza dureroasa tanar,fara sacroiliita, noduli Schmorl) discita TB spondiloza & Hiperostoza Vertebral! Forestier(culeu osteofitic vertebral, articula$ii sacro-iliacenormale)
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
28/44
ESTE BOALA...
SEVERA?
SEVERA?
SEVERA ?SEVERA ?
REFRACTARALA
TRATAMENT ?
REFRACTARALA
TRATAMENT ?
ACTIVA ?ACTIVA ?
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
29/44
RECOMANDARILE ASAS ACTIVITATEA SA
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
30/44
BASDAI: 7.6
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
31/44
RECOMANDARILE ASAS SEVERITATEA SA
AFECTAREA
MOBILITATII
AFECTAREA
FUNCTIONAL
BASMI
EVALUAREA
RADIOLOGICABASRI
BASFI
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
32/44
BASFI: 6.4Bath Ankylosing SpondylitisFunctional Index
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
33/44
FACTORI DE PROGNOSTIC
afectarea soldului (risc de 23 x de boalasevera)
SAU
VSH >30 mm/1h lipsa de raspunsla AINS limitarea mobilitatii coloanei lombare
dactilita
oligoartrita debutul
8/10/2019 C3_SA_Ancuta.pdf
34/44
Definitie & date epidemiologice
Mecanisme imuno-patogenetice
Investigatii paraclinice (biologice &
imagistice)
Management
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
35/44
Meninerea functiei &posturii (anchilloze,afectare respiratorie)
OBIECTIVE DE TRATAMENT
Incetinireaevolutiei
Ameliorareadurerii&
inflamatiei
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
36/44
MEDICAMENTOS
AINS & antalgiceRemisive DMARDs
(SSZ, MTX)
Terapia biologica
FIZICAL-KTRECUPERATOR
Electroterapie,laser-terapie,
hidroKT, KT(+respiratorie!)
CHIRURGICAL
Artroplastie totala
sold, genunchi
SA forma axiala
versus
SA formaperiferica
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
37/44
Anti-inflamatoriinon-steroidiene(AINS)
FORMAPERIFERICA
FORMAAXIALA
Ana
Recomandari EULAR/ASAS (2006)
Educaieterapie
fizicala &
Sulfasalazina
Blocante TNF
geZice
Corticoterapie locala
C
H
I
R
U
R
G
I
E
ASAS, Assessment in AS; EULAR, European League Against Rheumatism
balnea areabilitare/recuperare&terapie
de grup
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
38/44
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
39/44
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
40/44
Boala este refractara la tratamentcand estepersistent activa in ciuda
2 AINS adm continuu 3 luni fiecare, ladoze maxim recomandate sau toleratept SA axiala
AINS si SSZ in formele periferice, 4 lunide trat la doze maxim tolerate (3g/zi)
raspuns ineficient la cel putin o adm deCS injectabil local in artritele periferice si/sau entezitele active.
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
41/44
PROTOCOL TERAPIE BIOLOGICA Diagnostic cert de SA
conform crt. New York(1984); Boala activa si severa: BASDAI 6 de 4 sapt, VSH > 28mm/h,
CRP > 20 mg/l;
Screening TBanamnezaexamen clinic: normalRgf toracica: ITNIDR la 2 U PPD =22mm
Esecul terapiilor traditionale 2 AINS adm continuu 3luni fiecare, la doze maximrecomandate / tolerate
(SA forme axiale)
AINS si SSZ4 luni de trat ladoze max tolerate (3g/zi)(SA forma periferica)
Profilaxie HIN 300mg/zi, 6 luni
Screening markeri viralihepatici:
AgHBs- absentAc antiHVC - absenti
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
42/44
MONITORIZAREA SA SUB INHIBITORI TNF:12 sapt& 24 sapt
raspunsla tratamentactivitate si severitate SAefecte adverse
Continuarea tratamentdaca:
se inregistreaza ameliorare > 50% a BASDAIfata de momentul initierii terapiei sau ocu 2unitati si pe scala durerii axiale cu 2
se inregistreaza o a val. VSH si/sau CRP cu >50 % fata de valoarea de la initiereatratamentului
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
43/44
Factorii de predictie a unui raspuns
bun la terapia anti-TNF
boala cu debut recentrata de afectare functionala redusa
varsta tanaravalori crescute VSH, CRPprezenta sau riscul crescut de manifestari
extrarticulare
PDF created with pdfFactory trial version www.pdffactory.com
http://www.pdffactory.com/http://www.pdffactory.com/8/10/2019 C3_SA_Ancuta.pdf
44/44
Take home messages
SA, boala reum inflam cr, imuna, prototipul SpA teren genetic (HLAB27) & agregabilitate familial! afectare articulara axiala (inclusiv artic SI) &periferica, asimetrica, mb inf; entezite; dactilita
ulterioara markerul SA =sacro-iliita bilateral!, simetric! rg vertebrala sindesmofite, coloana de b a m b u s; terapie patogenica remisiva DMARDs pt SAperiferica; anti-TNF pt SA axiala & periferica non-responsivitate la corticoterapie sistemica